Page last updated: 2024-11-05

vigabatrin and Chromosome-Defective Micronuclei

vigabatrin has been researched along with Chromosome-Defective Micronuclei in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Vigabatrin (VGB) is an antiepileptic drug thatincreases brain γ-aminobutyric acid (GABA) levels through irreversible inhibition of GABA transaminase."1.43Genotoxic and mutagenic effects of vigabatrin, a γ-aminobutyric acid transaminase inhibitor, in Wistar rats submitted to rotarod task. ( Coelho, VR; de Souza, LP; Leal, MB; Papke, D; Pereira, P; Picada, JN; Pires, TR; Schunck, R; Sousa, K; Vieira, CG, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coelho, VR1
Sousa, K1
Pires, TR1
Papke, D1
Vieira, CG1
de Souza, LP1
Leal, MB1
Schunck, R1
Picada, JN1
Pereira, P1

Other Studies

1 other study available for vigabatrin and Chromosome-Defective Micronuclei

ArticleYear
Genotoxic and mutagenic effects of vigabatrin, a γ-aminobutyric acid transaminase inhibitor, in Wistar rats submitted to rotarod task.
    Human & experimental toxicology, 2016, Volume: 35, Issue:9

    Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Cerebral Cortex; Comet Assay; DNA Damage; Do

2016